Sheffield-based Westfield Health has acquired health cash plan provider Bolton & District Hospital Saturday Council (BDHSC).
BDHSC, trading as UK Healthcare, is a not-for-profit health provider with a nationwide corporate and consumer customer base and an annual turnover of £4m.
Established in 1877, BDHSC has a nationwide corporate and consumer customer base, and currently has a strong presence in the North West in particular.
International law firm Hogan Lovells is representing AXA, a worldwide leader in insurance and asset management, in the acquisition of employee health and benefits company Maestro Health for $155 million.
Completion of the transaction is subject to customary closing conditions, including the receipt of regulatory approvals, and is expected to take place before the end of first quarter of 2018.
The amount raised is one of the largest AIM secondary fundraising in the last 12 months and doubles the Company's market capitalisation.
The Energy team has recently completed a deal advising Mirabaud Securities Limited and Stifel Nicolaus Europe Limited on the AIM secondary fundraising by Diversified Gas & Oil plc, raising US$ 189 million. This will be used to fund acquisitions of oil and gas assets in the Appalachian basin in North America.
Davis Polk advised Dufry AG (Dufry) and its subsidiary, Hudson Ltd., in connection with the $748.9 million initial public offering of 39,417,765 Class A common shares of Hudson Ltd. The Class A common shares were sold by Dufry International AG, a wholly owned subsidiary of Dufry. Dufry International AG granted the underwriters an option to purchase up to an additional 5,912,664 Class A common shares of Hudson Ltd. to cover over-allotments, if any. The Class A common shares are listed on the New York Stock Exchange under the symbol “HUD.”
More than 350,000 sq ft of new office and research space, including a state of the art Biohub, is being created at Cambridge Science Park thanks to a landmark joint venture.
The landmark joint venture between Trinity College, Cambridge and Tus Park, the Science Park development body of Tsinghua University in Beijing, will inject over £200 million into a new phase of renewal and investment in Cambridge Science Park.
Baker McKenzie advised Al Zayani Investments on its acquisition of the 'Kreiller 214' project development in Munich from Bucher Properties.
The project development is a mixed use property with a lettable area of approx. 4,200 sqm located at Kreillerstraße 214 in Munich-Trudering. Anchor tenants will be Deutsche Postbank and FitStar. Completion of the project development is scheduled for Q1/2019.
Today, 5 February 2018, the Swedish mobile gaming operator LeoVegas starts trading on Nasdaq Stockholm. LeoVegas was previously listed on First North Premier.
Baker McKenzie is acting as legal adviser to LeoVegas in connection with the change of listing to Nasdaq Stockholm. Baker McKenzie's team consists mainly of Anders Fast, Joakim Falkner, Per Blom, Johanna Flink, Henric Roth, Stefan Balazs and Linnea Back.
Jones Day advised CVC Capital Partners in its $703 million acquisition of Teva Pharmaceutical Industries Ltd's International (non-US), Women's Health assets.
Contact: Raymond McKeeve
The Firm recently represented Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, Banco BTG Pactual S.A., Evercore Group L.L.C., Santander Investment Securities Inc., BCP Securities LLC and Banco Safra S.A., as initial purchasers, in an offering of US$150 million aggregate principal amount of additional 7% Senior Notes due 2025 by Gol Finance, a subsidiary of Gol Linhas Aéreas Inteligentes S.A. (“Gol”), the Brazilian airline.
Simpson Thacher recently represented the dealers in connection with Sumitomo Mitsui Banking Corporation’s (“SMBC”) update of its US$50 billion Global Medium Term Notes Program and the offering of US$1.25 billion of senior fixed rate notes and US$750 million of senior floating rate notes thereunder. The senior notes were guaranteed by SMBC’s New York branch and offered and sold in reliance on the exemption from SEC registration provided in Section 3(a)(2) of the Securities Act.